Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease.
Papatheodoridis, George V
Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease. [electronic resource] - Hepatology (Baltimore, Md.) Jul 2002 - 219-26 p. digital
Publication Type: Journal Article
0270-9139
10.1053/jhep.2002.33894 doi
Adult
Aged
Alanine Transaminase--blood
DNA, Viral--blood
Drug Resistance, Viral
Female
Hepatitis B e Antigens--analysis
Hepatitis B virus--genetics
Hepatitis B, Chronic--drug therapy
Humans
Kinetics
Lamivudine--administration & dosage
Liver--pathology
Male
Middle Aged
Mutation
Polymerase Chain Reaction
Recurrence
Remission Induction
Viremia
Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease. [electronic resource] - Hepatology (Baltimore, Md.) Jul 2002 - 219-26 p. digital
Publication Type: Journal Article
0270-9139
10.1053/jhep.2002.33894 doi
Adult
Aged
Alanine Transaminase--blood
DNA, Viral--blood
Drug Resistance, Viral
Female
Hepatitis B e Antigens--analysis
Hepatitis B virus--genetics
Hepatitis B, Chronic--drug therapy
Humans
Kinetics
Lamivudine--administration & dosage
Liver--pathology
Male
Middle Aged
Mutation
Polymerase Chain Reaction
Recurrence
Remission Induction
Viremia